Zinc and myocardial ischemia/reperfusion injury

被引：55
|
作者：
Xu, Zhelong [1 ]
Zhou, Juan [2 ]
机构：
[1] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Xian 710061, Shanxi, Peoples R China
来源：
BIOMETALS | 2013年 / 26卷 / 06期
关键词：
Zinc; Zinc homeostasis; Zinc transporters; Zinc signaling; Myocardial ischemia/reperfusion injury; PROTEIN-KINASE-C; GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR MTF-1; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; TYROSINE-PHOSPHATASE ACTIVITY; PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION INJURY; P70; S6; KINASE; MAMMALIAN ZINC; INTRACELLULAR ZINC;
D O I：
10.1007/s10534-013-9671-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
As an important trace element, zinc is required for the normal cellular structure and function, and impairment of zinc homeostasis is associated with a variety of health problems including cardiovascular disease. Zinc homeostasis is regulated through zinc transporters, zinc binding molecules, and zinc sensors. Zinc also plays a critical role in cellular signaling. Studies have documented that zinc homeostasis is impaired by ischemia/reperfusion in the heart and zinc dyshomeostasis may play a role in the pathogenesis of myocardial ischemia/reperfusion injury. Both exogenous and endogenously released zinc may play an important role in cardioprotection against ischemia/reperfusion injury. The goal of this review is to summarize the current understanding of the roles of zinc homeostasis and zinc signaling in myocardial ischemia/reperfusion injury.
引用
收藏
页码：863 / 878
页数：16
相关论文
共 50 条
  • [41] Sphingolipid therapy in myocardial ischemia-reperfusion injury
    Gundewar, Susheel
    Lefer, David J.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2008, 1780 (03): : 571 - 576
  • [42] Protective approaches against myocardial ischemia reperfusion injury
    Li, Xianchi
    Liu, Min
    Sun, Rongrong
    Zeng, Yi
    Chen, Shuang
    Zhang, Peiying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3823 - 3829
  • [43] Historical Perspective on the Pathology of Myocardial Ischemia/Reperfusion Injury
    Jennings, Robert B.
    CIRCULATION RESEARCH, 2013, 113 (04) : 428 - 438
  • [44] Myocardial ischemia and reperfusion: Mechanisms of injury and protection - Introduction
    Karmazyn, M
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1997, 75 (04) : 307 - 308
  • [45] Status of myocardial antioxidants in ischemia-reperfusion injury
    Dhalla, NS
    Elmoselhi, AB
    Hata, T
    Makino, N
    CARDIOVASCULAR RESEARCH, 2000, 47 (03) : 446 - 456
  • [46] Endoxin antagonist lessens myocardial ischemia reperfusion injury
    柯永胜
    王德国
    汪和贵
    杨尚印
    皖南医学院学报, 2005, (03) : 175 - 175
  • [47] THE EFFECT OF CHOLESTASIS ON MYOCARDIAL-ISCHEMIA REPERFUSION INJURY
    CRESTANELLO, JA
    KAHNG, KU
    KAMELGARD, J
    LIU, T
    LINGLE, D
    WHITMAN, GJ
    GASTROENTEROLOGY, 1995, 108 (04) : A1053 - A1053
  • [48] Regulated cell death in myocardial ischemia - reperfusion injury
    Xiang, Qi
    Yi, Xin
    Zhu, Xue-Hai
    Wei, Xiang
    Jiang, Ding-Sheng
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2024, 35 (03): : 219 - 234
  • [49] Trimetazidine ameliorates myocardial ischemia-reperfusion injury
    He, Chuanbo
    Cao, Shujun
    Tong, Zichuan
    Wang, Wenbin
    Zhang, Yin
    Guo, Changlei
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1691 - 1696
  • [50] Basis for Bicarbonate Damage in Myocardial Ischemia/Reperfusion Injury
    Queliconi, Bruno B.
    Cunha, Fernanda M.
    Gottlieb, Roberta A.
    Kowaltowski, Alicia J.
    CIRCULATION RESEARCH, 2014, 115
12345